Figure 5From: STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinomaSTAG2 expression and response to adjuvant therapy. Cumulative survival (y-axis) plotted versus time (x-axis) is compared for the 229 STAG2-deficient patients who received (n = 61) or did not receive (n = 168) adjuvant chemotherapy. Mo, months.Back to article page